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Craniometaphyseal dysplasia is a rare genetic condition characterized by progressive thickening of 
bones in the skull and metaphyseal abnormalities in the long bones.  This disorder often causes pro-
gressively symptomatic cranial nerve compression,  but in rare cases foramen magnum stenosis may 
lead to quadriplegia.  Chiari I malformation with craniometaphyseal dysplasia is extremely rare.  The 
authors report on a 25-year-old woman with myelopathy due to Chiari I malformation along with 
craniometaphyseal dysplasia.  There are only four previous case reports of this condition.  The authors 
present here the ﬁfth case report of this rare condition and summarize its characteristics.
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raniometaphyseal dysplasia (CMD) is a rare 
systemic bone disorder ﬁrst reported by 
Jackson et al.  in 1954 [1].  CMD is characterized by 
skull sclerosis presenting during childhood.  Clinically,  
patients exhibit facial distortion,  hampered cognition 
due to cranial nerve compression,  and headaches from 
increased intracranial pressure [1].  Patients with 
craniometaphyseal dysplasia usually have a normal life 
span except in severe cases.  However,  in rare cases,  
foramen magnum compression contributes to medulla 
dysfunction,  which is thought to cause fatal problems 
[2,  3].  Chiari I malformation with craniometaphy-
seal dysplasia is an extremely rare condition,  ﬁrst 
reported by Day et al.  in 1997 [3],  with only 3 other 
published case reports [4-6].  We present here the 
ﬁfth case of Chiari I malformation with CMD and 
summarize this conditionʼs characteristics.
Case Report
　 Patient history. A 25-year-old woman pre-
sented to our department with progressive quadriple-
gia over a 2-year period.  She had had a normal 
delivery with a birthweight of 3,000g.  Skeletal abnor-
malities were noted at birth; however,  further diag-
nostics were not performed at that time.  By 3 years 
of age,  she had strabismus and amblyopia and was 
diagnosed with CMD at a national hospital.  She expe-
rienced hearing loss by age 7,  vertigo and tinnitus by 
age 13 and had surgery for facial nerve palsy when she 
was 21 years old.  Gradually,  she began suﬀering 
from neck pain,  headache,  nausea,  and numbness of 
the hands,  so she visited our hospital.  She had no 
signiﬁcant perinatal or family history.
　 Physical examination. On examination,  she 
was able to walk without any support and had mild 
muscle weakness (MMT 4/5).  She also had some 
sensory disturbance of her hands.  All her extremities 
showed spasticity and hyperreﬂexia.  The physical 
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examination revealed bossing of the forehead with 
bitemporal narrowing.  She had vertigo,  nausea and 
sleep apnea syndrome but no ataxia nor dysphasia.  
Other systems were clinically normal.
　 Laboratory ﬁndings. Laboratory ﬁndings 
were as follows: Ca,  9.3mg/dl (reference range,  8.2-
10.4mg/dl); P,  5.4mg/dl (reference range,  4.5-6.7 
mg/dl); calcitonin (CT),  31pg/ml (reference range:
＜100pg/ml); parathyroid hormone (PTH),  43pmol/L 
(reference range: 1.3-7.5pmol/L); bone alkaliphos-
phatase,  51.1U/l; urine NTx 45.9nMBC.
　 Imaging. Plain radiographs of the cranial bone 
revealed increased bone density,  hyperostosis and 
sclerosis of the calvarium,  skull base and other bones 
(Fig.  1).  The patient underwent magnetic resonance 
imaging (MRI),  on which we identiﬁed Chiari I mal-
formation and compression of the medulla (Fig.  2).  
Computerized tomography (CT) showed extreme thick-
ness of the skull (Fig.  3).  We diagnosed her as having 
Chiari I malformation with craniometaphyseal dyspla-
sia.  Because of the severity of her disease and the 
risks associated with surgery,  she has chosen to 
remain under careful observation at this time.
Discussion
　 CMD is a rare genetic disorder of bone remodeling 
caused by a failure of osteoclasis,  and determined by 
an autosomal dominant or recessive inheritance [4].  
The dominant and mild form of this disorder is due to 
a gene abnormality in chromosome region 5p15.2-
p14.1.  This abnormality is located in the ankylosis 
(ANK) gene which encodes a protein involved in the 
transport of pyrophosphate into the bone matrix [5].  
On the other hand,  clinical features of autosomal 
recessive CMD with the gene abnormality located in 
chromosome region 6q21-22,  the function of which is 
not yet known,  are typically more severe than those of 
the autosomal dominant form [7].  The penetrance of 
CMD is close to 100ｵ,  and males and females are 
equally aﬀected.  CMD is so rare that epidemiology 
has not yet been established,  so the exact occurrence 
rate is unclear.
　 CMD is often detected within the ﬁrst few weeks 
of life because breathing or feeding problems occur 
due to choanal stenosis [8-11].  Its prominent clinical 
symptoms are characterized by certain facial features.  
Patients typically have a wide nasal bridge,  paranasal 
bossing,  wide-set eyes (ocular hypertelorism) with an 
increase in bizygomatic width,  and a prominent man-
dible [4].  A long skull shape (dolichocephaly) result-
ing from fronto-occipital hyperostosis has also been 
reported.  Progressive thickening of craniofacial bones 
continues throughout life as in our case.  As a result,  
it often narrows the cranial foramina and rarely 
includes the foramen magnum.  If this condition is not 
treated,  compression of the cranial nerves can lead to 
disabling conditions such as facial palsy,  blindness,  or 
deafness [12].  Furthermore,  associated Chiari I 
malformation can sometimes lead to severe headaches 
and myelopathy [4].
　 The diagnosis of CMD is based on clinical and 
radiographic ﬁndings [1],  although blood tests are 
sometimes helpful because serum alkaline phosphatase 
and parathyroid hormone can be elevated [13],  osteo-
calcin is usually decreased [14],  and the blood cal-
cium and phosphate concentrations are within normal 
limits [15].  Sequence analysis of the ANK gene 
detects mutation in approximately 90ｵ of patients 
with CMD [16].  Diﬀerential diagnoses include meta-
physeal dysplasia,  craniodiaphyseal dysplasia,  fronto-
metaphyseal dysplasia and osteopathia striata with 
cranial sclerosis.
　 Individuals with typical autosomal dominant CMD 
have a normal life expectancy [4],  while patients with 
the severe forms of CMD can expect a reduced life 
expectancy as a result of compression of the foramen 
magnum [3,  9].  Treatment consists primarily of 
surgery to reduce compression of cranial nerves,  the 
brain stem and the spinal cord at the level of the fora-
men magnum [3,  9,  10].  Day et al.  were the ﬁrst to 
report a good surgical outcome of a CMD patient who 
also had the Chiari I malformation and compression of 
the medulla [4].  The cause of Chiari malformation 
associated with CMD is not clear,  but its increased 
internal pressure may play an important role in her-
niation of the cerebellum.  With our current report,  
there are only 5 case reports [3,  9,  10] of this condi-
tion.  Table 1 is a summary of the 5 cases.  Spastic 
quadriplegia beginning as a young adult is the typical 
clinical symptom.  Two cases had a large syrinx which 
contributed to motor paralysis.  The 4 cases with 
foramen magnum decompression surgery had good 
outcomes.  Our patient,  however,  had neither a syrinx 
nor severe symptoms,  so she declined our recom-
mended surgical intervention and opted for continued 
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Fig. 1　 Plain skeletal radiographs.  A,  plain radiographs of the cranial bone revealed increased bone density (white arrow); B,  spinal 
bone density of spine was increased; C,  bony deformities and increased bone density were observed.
observation.  Garvia reported that an increase in the 
cranial vault thickness may result in extremely high 
pressure of the dural sinuses and thus an increase in 
intracranial pressure [6].  The indication and timing 
for surgical intervention are controversial in patients 
with mild myelopathy,  because FMD for this kind of 
patient potentially has a high risk of deterioration due 
to surgery and the high recurrence rate.
　 The Chiari malformation,  which is deﬁned as a 
cerebellar tonsil extension below the foramen magnum,  
was ﬁrst described in 1891 by Chiari [19].  Many 
patients with Chiari malformation have no signs or 
symptoms and do not need treatment.  However,  some 
patients with Chiari malformation will have gait dis-
turbances,  numbness and tingling of the hands and 
feet,  dizziness,  dysphasia,  and sometimes life-
threatening problems.  It is important to closely follow 
patients with mild symptoms so as not to miss the best 
timing for surgery [20].  Symptomatic Chiari I mal-
formation with craniometaphyseal dysplasia is 
extremely rare,  but it is important to survey cervical 
spine MRIs if patients have symptoms such as gait 
disturbance,  numbness,  dizziness,  dysphasia and 
hyperreﬂexia.
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Fig. 2　 Magnetic resonance imaging of head.  Note the Chiari I malformation (white arrow) and compression of the medulla (gray arrow).
Fig. 3　 Computerized tomography of skull.  CT showed extreme thickness of the skull (white arrow).
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Table 1　 Patientsʼ demographic of CMD and Chiari I malformation
Author Year Age Gender Symptom Syrinx Surgery Result
Day et al. 1997 15y F headache, spastic quadriplegia Yes
C3-T10
Yes
FMD
Improve
Sewell et al. 2008 35y F cough, headache, neck stiﬀness,
thoracic back pain, arm paraesthesis
Yes
C3-T1
Yes
FMD
Improve
Cai et al. 2008 11m M spastic quadriplegia No Yes
FMD
Improve
Garvia et al. 2011  6y M headache, loss of visual acuity No Yes
CVE
Improve
This study 2013 25y F headache, neck pain, nausea, 
arm numbness, spastic quadriplegia
No No －
CMD,  craniometaphyseal dysplasia; FMD,  foramen magnum decompression; CVE,  cranial vault expansion.
